Viewing data from:

AMINOPHYLLINE

ANDA

AMINOPHYLLINE | A084568 | ABRAXIS PHARMACEUTICAL PRODUCTS

1 strength0 unique patents0 unique exclusivities

Medicare Part B Spending

CMS physician-administered drug spending for Aminophylline (2023)

Total Spending

$381K

Total Claims

41,609

Beneficiaries

41,291

ASP Price

—

HCPCS: J0280 — Injection, aminophyllin, up to 250 mg

Source: CMS Medicare Part B Spending by Drug (2023). Shows physician-administered drug costs.

API Supply Chain0 active DMFs1 inactive

0 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

KNOLL AG LUDWIGSHAFENInactiveAMINOPHYLLINE

DMF 49171983

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 25MG/ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.